An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA

  title={An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA},
  author={J. Tyndall and R. Gerona and Giuliano De Portu and J. Trecki and Marie-Carmelle Elie and J. Lucas and J. Slish and K. Rand and Lindsay A L Bazydlo and Martina C Holder and M. Ryan and P. Myers and Nicole M Iovine and M. Plourde and E. Weeks and J. R. Hanley and G. Endres and D. St Germaine and Paul J. Dobrowolski and M. Schwartz},
  journal={Clinical Toxicology},
  pages={950 - 956}
  • J. Tyndall, R. Gerona, +17 authors M. Schwartz
  • Published 2015
  • Medicine
  • Clinical Toxicology
  • Background: Synthetic cannabinoid containing products are a public health threat as reflected by a number of outbreaks of serious adverse health effects over the past 4 years. The designer drug epidemic is characterized by the rapid turnover of synthetic cannabinoid compounds on the market which creates a challenge in identifying the particular etiology of an outbreak, confirming exposure in cases, and providing current information to law enforcement. Results: Between 28 May 2014 and 8 June… CONTINUE READING
    New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics
    • 44


    Publications referenced by this paper.
    Pharmacology of cannabinoid CB1 and CB2 receptors.
    • 1,311
    Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.
    • 193
    • PDF
    Cannabinoid Receptors: Where They are and What They do
    • 330
    • PDF
    Synthetic Cannabinoid-Related Illnesses and Deaths.
    • 176
    • PDF
    In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
    • 43
    • PDF